Hepatocellular carcinoma has a substantial global mortality burden which is rising despite
advancements in tackling the traditional viral risk factors. Metabolic (dysfunction) associated …

Metabolic (dysfunction) associated fatty liver disease (MAFLD), previously known as non-
alcoholic fatty liver disease, is the most common cause of chronic liver disease worldwide …

Metabolic-associated fatty liver disease (MAFLD) is characterized by hepatic steatosis
accompanied by one of three features: overweight or obesity, T2DM, or lean or normal …

Background Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a new
inclusive definition of the whole spectrum of liver diseases associated to metabolic …

Simple Summary Metabolic-dysfunction-associated steatotic liver disease (previously known
as non-alcoholic fatty liver disease) is a term for a range of liver conditions in which excess …

The prevalence of metabolic (dysfunction)-associated fatty liver disease (MAFLD) is rapidly
increasing and affects up to two billion individuals globally, and this has also resulted in …

Metabolic‐associated fatty liver disease (MAFLD) is a major cause of liver‐related
complications, including hepatocellular carcinoma (HCC). While MAFLD‐related HCC is …

Simple Summary The global prevalence of metabolic-associated fatty liver disease (MAFLD)
is rising due to urbanization, obesity, poor diet, sedentary lifestyles, and genetic factors. We …

Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is currently the most common
chronic liver disease and affects at least a quarter of the global adult population. It has …

Fatty liver is now a major cause of liver disease in the Asia-Pacific region. Liver diseases in
this region have distinctive characteristics. First, fatty liver is frequently observed in …